2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Longitudinal free-water changes in dementia with Lewy bodies

S. Chiu, R. Chen, W. Wang, M. Armstrong, B. Boeve, K. Kantarci, D. Vaillancourt (Gainesville, USA)
Longitudinal imaging of regional volumes, presynaptic terminals and glucose metabolism in brains of people with early Huntington’s disease

A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)
Longitudinal recordings of subthalamic local field potentials show intra-subject consistency of beta-based physiomarkers in Parkinson’s Disease

M. Stam, B. van Wijk, A. Buijink, D. Piña-Fuentes, R. de Bie, R. Schuurman, M. Beudel (Amsterdam, Netherlands)
Low Beta-Band Suppression as a Tool for DBS Contact Selection for Akinetic-rigid Symptoms in Parkinson’s Disease

J. Strelow, T. Dembek, J. Baldermann, P. Andrade, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)
Low serum vitamin E in a genetically confirmed Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)

D. Al-Shorafat, K. Al-Hayk, M. Qawasmeh, W. Kamel, S. Bashayreh (Irbid, Jordan)
Low Vision Occupational Therapy for Parkinson’s Disease – A Pilot Study at the University of Alabama at Birmingham

C. Parker, M. Maher, J. Vice, L. Lieb, M. Dean (BIRMINGHAM, USA)
LRRK2 G2019S as a trigger of inflammatory signaling in patient-derived microglia

K. Badanjak, P. Mulica, M. Tziortziou, S. Delcambre, S. Smajic, C. Venegas, M. Ali, T. Rolova, J. Koistinaho, P. Seibler, S. Cowley, J. Trinh, S. Pereira, P. Antony, E. Glaab, A. Grünewald (Esch-sur-Alzette, Luxembourg)
LRRK2 G2019S mutation in Multiple System Atrophy, a case report

T. Carrer, G. Bonato, M. Sandre, A. Emmi, A. Antonini (Padova, Italy)
LRRK2 G2019S promotes astrocytic inflammatory response induced by oligomeric α-synuclein through NF-κB pathway

JY. Liu, KJ. He, JB. Zhang, F. Wang, CF. Liu (Suzhou, China)
LRRK2 Inhibition by BIIB122/DNL151 Demonstrates Robust Target and Lysosomal Engagement: Pharmacokinetics, Pharmacodynamics and Safety in Phase 1 and Phase 1b Studies in Healthy and Parkinson’s Participants

S. Dhuria, P. Roychowdhury, H. Wong, S. Huntwork-Rodriguez, H. Solanoy, M. Goo, R. Maciuca, O. Mabrouk, K. Fraser, K. Scearce-Levie, D. Graham, D. Jennings, M. Troyer (South San Francisco, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z